EGF and gastric cancer: Moreover, FLOT1 mediates the levels of heterotypic signaling molecules, including TNF-α, EGF, HGF, and IGF1, across various cancers, such as breast, prostate, and gastric cancer, and oral squamous cell carcinoma [9, 15, 17, 35, 42].